Medindia

X

Surveyed Physicians Anticipate an Increase in Their Use of Combination Therapy for the Treatment of Generalized Anxiety Disorder in Treatment-Refractory Patients

Tuesday, August 3, 2010 Hospital News J E 4
Advertisement
Atypical Antipsychotics and SNRIs Will See the Greatest Growth in GAD Patient Share Over the Next Two Years, According to a New Report from Decision Resources

For more information, contact:

Decision Resources

Decision Resources, Inc.

Lisa Osgood

Chris Comfort

781-296-2606

781-296-2597

losgood@hl-isy.com

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Qu...
S
Victory Pharma Completes Acquisition of Assets of ...